SC 13G/A | 2013-10-03 | Redmile Group, LLC | Cyclacel Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
SC 13G | 2013-05-28 | Eastern Capital LTD | Cyclacel Pharmaceuticals, Inc. | 1,250,000 | 7.1% | EDGAR |
SC 13G/A | 2013-04-02 | TANG CAPITAL PARTNERS LP | Cyclacel Pharmaceuticals, Inc. | 765,198 | 7.1% | EDGAR |
SC 13G | 2013-02-14 | Redmile Group, LLC | Cyclacel Pharmaceuticals, Inc. | 672,680 | 7.4% | EDGAR |
SC 13G | 2013-01-02 | TANG CAPITAL PARTNERS LP | Cyclacel Pharmaceuticals, Inc. | 631,561 | 7.0% | EDGAR |
SC 13G | 2012-04-06 | Redmile Group, LLC | Cyclacel Pharmaceuticals, Inc. | 5,329,095 | 9.0% | EDGAR |
SC 13G/A | 2011-11-08 | MARXE AUSTIN W & GREENHOUSE DAVID M | Cyclacel Pharmaceuticals, Inc. | 2,847,448 | 5.0% | EDGAR |
SC 13G/A | 2011-08-09 | MARXE AUSTIN W & GREENHOUSE DAVID M | Cyclacel Pharmaceuticals, Inc. | 6,680,973 | 11.7% | EDGAR |
SC 13G/A | 2011-02-11 | MARXE AUSTIN W & GREENHOUSE DAVID M | Cyclacel Pharmaceuticals, Inc. | 9,911,148 | 19.3% | EDGAR |
SC 13G/A | 2011-02-11 | CAPITAL VENTURES INTERNATIONAL /E9/ | Cyclacel Pharmaceuticals, Inc. | 1,371,960 | 2.5% | EDGAR |
SC 13G/A | 2010-12-10 | MORGAN STANLEY | Cyclacel Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2010-12-02 | MARXE AUSTIN W & GREENHOUSE DAVID M | Cyclacel Pharmaceuticals, Inc. | 10,111,148 | 19.3% | EDGAR |
SC 13G | 2010-11-10 | MARXE AUSTIN W & GREENHOUSE DAVID M | Cyclacel Pharmaceuticals, Inc. | 7,030,973 | 14.6% | EDGAR |
SC 13G | 2010-10-18 | CAPITAL VENTURES INTERNATIONAL /E9/ | Cyclacel Pharmaceuticals, Inc. | 2,464,065 | 5.4% | EDGAR |
SC 13G/A | 2010-10-12 | MARXE AUSTIN W & GREENHOUSE DAVID M | Cyclacel Pharmaceuticals, Inc. | 1,617,734 | 4.3% | EDGAR |
SC 13G/A | 2010-02-12 | MORGAN STANLEY | Cyclacel Pharmaceuticals, Inc. | 2,618,514 | 9.9% | EDGAR |
SC 13G | 2010-01-12 | MARXE AUSTIN W & GREENHOUSE DAVID M | Cyclacel Pharmaceuticals, Inc. | 2,783,224 | 11.4% | EDGAR |
SC 13G/A | 2009-09-10 | FEDERATED INVESTORS INC /PA/ | Cyclacel Pharmaceuticals, Inc. | 1,107,143 | 4.3% | EDGAR |
SC 13D | 2009-08-03 | MARXE AUSTIN W & GREENHOUSE DAVID M | Cyclacel Pharmaceuticals, Inc. | 6,597,093 | 24.1% | EDGAR |
SC 13G/A | 2009-02-17 | MORGAN STANLEY | Cyclacel Pharmaceuticals, Inc. | 2,991,824 | 14.6% | EDGAR |